Value of infliximab (Remicade®) in patients with low-risk myelodysplastic syndrome: final results of a randomized phase II trial (EORTC trial 06023) of the EORTC Leukemia Group
about
Evidence of selective reporting bias in hematology journals: A systematic review.Inflammatory arthritis in patients with myelodysplastic syndromes: a multicenter retrospective study and literature review of 68 cases.A comprehensive review of myelodysplastic syndrome patients with autoimmune diseases.New Insights into the Pathogenesis of MDS and the rational therapeutic opportunities.Infliximab therapy in hematologic malignancies: handle with care.Reply to “Infliximab therapy in hematologic malignancies: handle with care” 2012;97(8):e26.Infliximab associated with life-threatening lung infection in a patient with Behcet disease with intestinal and hematopoietic system involvement: A case report.Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia
P2860
Q33751652-CC22BD3D-6B62-40C3-A44C-77E8F5C2C412Q36193594-35B49353-84BC-42C0-BEDE-ED46BFA57E73Q38259434-1FB7044F-1122-476B-A8E4-16F3BA1A43CCQ38687894-A6289A2E-39A3-419F-9091-F8EF8FFBFF72Q43235077-3D08408F-71B1-4967-9191-D245BD742A2EQ46488130-73253216-4251-44B6-93D3-E438662514F3Q47547344-1B03AF85-2160-433C-BCEC-60A1A6731CF3Q58777077-D08B503E-1049-47B9-8908-1797253B5AF1
P2860
Value of infliximab (Remicade®) in patients with low-risk myelodysplastic syndrome: final results of a randomized phase II trial (EORTC trial 06023) of the EORTC Leukemia Group
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Value of infliximab (Remicade® ...... 3) of the EORTC Leukemia Group
@ast
Value of infliximab (Remicade® ...... 3) of the EORTC Leukemia Group
@en
type
label
Value of infliximab (Remicade® ...... 3) of the EORTC Leukemia Group
@ast
Value of infliximab (Remicade® ...... 3) of the EORTC Leukemia Group
@en
prefLabel
Value of infliximab (Remicade® ...... 3) of the EORTC Leukemia Group
@ast
Value of infliximab (Remicade® ...... 3) of the EORTC Leukemia Group
@en
P2093
P2860
P1433
P1476
Value of infliximab (Remicade® ...... 3) of the EORTC Leukemia Group
@en
P2093
Antoine Thyss
Claudio Denzlinger
Dominik Selleslag
Frédéric Baron
Gert Ossenkoppele
Heinz Zwierzina
Karel Indrak
Michel Delforge
Sergio Amadori
Stefan Suciu
P2860
P304
P356
10.3324/HAEMATOL.2011.044347
P50
P577
2011-11-18T00:00:00Z